Microsoft and Anthropic in Early Talks for Custom AI Chip Deal Following 5 Billion Investment Canadian Biotech Sector Three Firms Draw Attention for 2026 Growth Potential American Hospital Association Urges FTC and DOJ to Exempt Hospital Mergers from Premerger Notification Requirements 3M India Announces 506 Per Share Dividend Including Special Payout Reports 202 Profit Surge in Q4 FY26 JDcom Founder Pledges to Protect 900000 Workers from AI Displacement with Massive Retraining Initiative Kevin Warsh Takes Helm at Federal Reserve Amid Trumps Push for Lower Rates Market Bets on Extended Hold JOBY Q1 2026 Earnings EPS Beat Narrowing Losses as eVTOL Development Progresses HGTY Q1 2026 Earnings NarrowerThanExpected Loss Drives Small Beat Shares Slip Heritage Insurance Holdings Inc HRTG Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares 7 MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline Commercecom Inc Series 1 CMRC Q1 2026 Earnings EPS Beat Drives Positive Market Reaction VirTra Inc VTSI Edges Higher Consolidation Near Key Support Intuitive Surgical ISRG Holds Steady Near 438 as Traders Weigh Support Levels Silgan Holdings SLGN Holds Steady Near 38 as Shares Consolidate Between Key Support and Resistance Blackbaud BLKB Rallies 12 as Software Stock Approaches Resistance at 3192 PodcastOne Inc PODC Surges 667 Key Levels and Market Dynamics Retail Investors Boost Stakes in Vedanta MCX and 8 Other Stocks in Q4 Japanese Snack Maker Behind Shiruko Sand Eyes Singapore and Southeast Asia for Expansion Oil Prices Advance as Markets Question Prospects for USIran Diplomatic Breakthrough GLOBALFOUNDRIES Inc Announces Quantum Technology Solutions Initiative ADP Private Payrolls Rising 109000 in April Surpass Expectations Signaling a Resilient Labor Market AnheuserBusch InBev Shares Edge Lower as Revenue Misses Analyst Forecasts Dillards Declares 030 Per Share Cash Dividend Continuing Shareholder Return Policy Intrusion Inc INTZ Q1 2026 Earnings Earnings Miss Weighs Heavily as Revenue Data Remains Absent Allogene Therapeutics ALLO Surges 755 as Biotech Momentum Builds